Correlation Between Rhythm Pharmaceuticals and Adverum Biotechnologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rhythm Pharmaceuticals and Adverum Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rhythm Pharmaceuticals and Adverum Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rhythm Pharmaceuticals and Adverum Biotechnologies, you can compare the effects of market volatilities on Rhythm Pharmaceuticals and Adverum Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rhythm Pharmaceuticals with a short position of Adverum Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rhythm Pharmaceuticals and Adverum Biotechnologies.

Diversification Opportunities for Rhythm Pharmaceuticals and Adverum Biotechnologies

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Rhythm and Adverum is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Rhythm Pharmaceuticals and Adverum Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adverum Biotechnologies and Rhythm Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rhythm Pharmaceuticals are associated (or correlated) with Adverum Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adverum Biotechnologies has no effect on the direction of Rhythm Pharmaceuticals i.e., Rhythm Pharmaceuticals and Adverum Biotechnologies go up and down completely randomly.

Pair Corralation between Rhythm Pharmaceuticals and Adverum Biotechnologies

Given the investment horizon of 90 days Rhythm Pharmaceuticals is expected to generate 1.16 times more return on investment than Adverum Biotechnologies. However, Rhythm Pharmaceuticals is 1.16 times more volatile than Adverum Biotechnologies. It trades about 0.26 of its potential returns per unit of risk. Adverum Biotechnologies is currently generating about -0.29 per unit of risk. If you would invest  4,943  in Rhythm Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of  1,252  from holding Rhythm Pharmaceuticals or generate 25.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Rhythm Pharmaceuticals  vs.  Adverum Biotechnologies

 Performance 
       Timeline  
Rhythm Pharmaceuticals 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Rhythm Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Rhythm Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.
Adverum Biotechnologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adverum Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Rhythm Pharmaceuticals and Adverum Biotechnologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rhythm Pharmaceuticals and Adverum Biotechnologies

The main advantage of trading using opposite Rhythm Pharmaceuticals and Adverum Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rhythm Pharmaceuticals position performs unexpectedly, Adverum Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will offset losses from the drop in Adverum Biotechnologies' long position.
The idea behind Rhythm Pharmaceuticals and Adverum Biotechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Technical Analysis
Check basic technical indicators and analysis based on most latest market data